Brian M. Stolz, EVP, Administration and CHCO at Valeant Pharmaceuticals International, Inc. (VRX), bought 2,550 shares at $39.21 ($100K) on 2011-08-11, disclosed to the SEC on 2011-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.10 | 750 | $29K | 29.4% |
| 2 | $39.21 | 1,800 | $71K | 70.6% |
| Total | $39.18 avg | 2,550 | $100K | 100% |
| Filing → |
| VRX | BUY | 2012-11-08 | $108K | — | Filing → |
| VRX | BUY | 2012-05-14 | $266K | — | Filing → |
| VRX | BUY | 2011-11-18 | $101K | — | Filing → |